After a recent, highly public failure in regulatory oversight of genetically engineered crop development, a new coalition has formed to push the USDA to review the activities of agricultural biotechnology companies with a keener eye. Watch this video to find out what the issues are, and what this new development might mean for companies.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
A new coalition may have the clout to force USDA's hand on ag biotech oversight.
Sara Murphy has no position in any stocks mentioned. Follow her on Twitter @SMurphSmiles. The Motley Fool recommends Scotts Miracle-Gro. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
Monsanto Company
MON
The Dow Chemical Company
DOW
Scotts Miracle-Gro
SMG
$69.00
(2.83%)
$1.90
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Forget Kinder Morgan -- Where Will Enterprise Products Partners Be in 10 Years?
Investing $1,000 Into This Top Dividend Stock in July Could Grow to Over $4,250 by 2035
1 Dividend Giant Paying Over 7%, With Big Things Coming
Why MP Materials Stock Powered Almost 53% Higher in June
Why Energy Fuels Stock Lit Up Today
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.